Technical University of Munich: Clinical Trials

6 trials sponsored by Technical University of Munich, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 31Terminated 1

Follow Technical University of Munich: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
Mycophenolate Mofetil, Prednisolone, Mycophenolate Mofetil Placebo - Inflammatory Cardiomyopathy
Phase 2 / Phase 3TerminatedLMU Klinikum92023-03-282025-07-25
Synaptic Plasticity and Cognitive Function in RASopathies
Lovastatin, Lamotrigine - Impaired Synaptic Plasticity, Impaired Cognition
Phase 2TerminatedTechnical University of Munich162019-03-222023-11-30
A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
Cannabidiol, Olanzapine, Placebo Cannabidiol - Schizophrenia
Phase 2TerminatedCentral Institute of Mental Health, Mannheim1502015-12-082024-12-27
Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)
Panobinostat (LBH589) - Metastatic Gastric Cancer
Phase 2TerminatedTechnical University of Munich282009-06-012013-05-01
Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy
everolimus - Lymphoma
Phase 2TerminatedTechnical University of Munich352008-05-012012-12-17
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
MabThera - Grafting, Renal Transplantation
Phase 2TerminatedTechnical University of Munich2002007-12-012009-10-01

Conditions studied

Cognition Disorders (1)  ·  Heart Failure (1)  ·  Lymphoma (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Myocarditis (1)  ·  Neurofibromatosis 1 (1)  ·  Noonan Syndrome (1)  ·  Schizophrenia (1)  ·  Stomach Neoplasms (1)

Interventions

Cannabidiol (1)  ·  Everolimus (1)  ·  Lamotrigine (1)  ·  Lovastatin (1)  ·  Mycophenolic Acid (1)  ·  Olanzapine (1)  ·  Panobinostat (1)  ·  Prednisolone (1)  ·  Rituximab (1)

Countries

Germany (6)  ·  Denmark (1)

Top investigators

F. Markus Leweke, MD (1)  ·  Martina Mayr, Dr. (1)  ·  Steffen Massberg, Prof Dr. med. (1)  ·  Ulrich Keller, MD (1)  ·  Uwe Heemann, Prof. MD (1)

Results publications

PMID 37280688

NIH funding

2016 (1)